John Graham

发表

Adjuvant bleomycin, vincristine and cisplatin (BOP) for high-risk stage I non-seminomatous germ cell tumours: a prospective trial (MRC TE17)

M. Williams, S. Fosså, D. Dearnaley, 2005, British Journal of Cancer.

Abiraterone acetate plus prednisolone with or without enzalutamide for patients with metastatic prostate cancer starting androgen deprivation therapy: final results from two randomised phase 3 trials of the STAMPEDE platform protocol.

M. Parmar, M. Sydes, D. Dearnaley, 2023, The Lancet. Oncology.